Washington University
In its 13F for Q2 2026 (holdings as of June 30, 2026, filed July 14, 2026), Washington University reported 3 stock positions worth $264.8 million. Its top holding was Nu Holdings Ltd./Cayman Isl-A (NU) at 53.3% of the portfolio, followed by Cerebras Systems Class A (CBRS, 46.0%) and Rubrik Class A (RBRK, 0.7%). Compared with Q1 2026, it opened 2 new positions and sold out of 1. The biggest buy was a new position in Cerebras Systems Class A (CBRS) and the biggest sale an exit from Maze Therapeutics (MAZE).
- Most Recent 13F
- Q2 2026
- Location
- ST LOUIS, MO
- CIK
- 0000903603
- Portfolio Value
- $264.8M (Q2 2026)
- SEC Filing
- 0000903603-26-000005 ↗ filed Jul 14, 2026
Holdings Value
Holdings 3 stocks · $264.8M
Portfolio Sells Q1 2026 → Q2 2026
| MAZE Maze Therapeutics Inc. | Sold out | 0.00% | −5.23 |
Portfolio Buys Q1 2026 → Q2 2026
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 3 | $264.8M | NU, CBRS, RBRK |
| Q1 2026 | 2 | $160.2M | NU, MAZE |
| Q4 2025 | 5 | $197.8M | NU, MAZE, MRNA, RBRK, FIG |
| Q3 2025 | 3 | $178.5M | NU, MAZE, MRNA |
| Q2 2025 | 4 | $121.4M | NU, IOT, MRNA, PONY |
| Q1 2025 | 2 | $110.8M | NU, MRNA |
| Q4 2024 | 3 | $117.5M | NU, MRNA, ROAD |
| Q3 2024 | 4 | $154.2M | NU, MRNA, UTI, CART |
| Q2 2024 | 3 | $219.7M | NU, MRNA, UTI |
| Q1 2024 | 5 | $270.4M | NU, UTI, CPNG, MRNA, U |